Patents by Inventor Stefan Lorenzl

Stefan Lorenzl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases
    Patent number: 8093258
    Abstract: The present invention relates to methods and compositions for the treatment and/or prevention of neuropathological and/or neurodegenerative diseases. In particular, the invention delivers novel uses of inhibitors of Urokinase-type Plasminogen activator in the treatment of amyotrophic lateral sclerosis.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: January 10, 2012
    Assignee: Wilex AG
    Inventors: Stefan Lorenzl, Wolfgang Schmalix
  • USE OF RASAGILINE FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
    Publication number: 20110130466
    Abstract: A method for the treatment of Progressive Supranuclear Palsy. Such method includes administering to a subject an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 8, 2010
    Publication date: June 2, 2011
    Inventor: Stefan Lorenzl
  • Use Of Urokinase Inhibitors for the Treatment and/or Prevention of Neuropathological Diseases
    Publication number: 20090069251
    Abstract: The present invention relates to methods and compositions for the treatment and/or prevention of neuropathological and/or neurodegenerative diseases. In particular, the invention delivers novel uses of inhibitors of Urokinase-type Plasminogen activator in the treatment of amyotrophic lateral sclerosis.
    Type: Application
    Filed: June 22, 2006
    Publication date: March 12, 2009
    Inventors: Stefan Lorenzl, Wolfgang Schmalix